Table 4.
Side effect assessment*
| Aripiprazole (N=16) | Placebo (N=14) | p | |||
|---|---|---|---|---|---|
| Adverse event | N | % | N | % | |
| Over-arousal | 3 | 19 | 0 | 0 | 0.271 |
| Drowsiness | 4 | 25 | 1 | 7 | 0.413 |
| Itching | 2 | 13 | 0 | 0 | 0.527 |
| Headache | 3 | 19 | 1 | 7 | 0.689 |
| Chest pain | 3 | 19 | 1 | 7 | 0.689 |
| Back pain | 2 | 13 | 0 | 0 | 0.527 |
| Nasal congestion | 5 | 31 | 1 | 7 | 0.235 |
| Hypersalivation | 3 | 19 | 0 | 0 | 0.271 |
| Nausea | 4 | 25 | 1 | 7 | 0.413 |
| Vomiting | 3 | 19 | 0 | 0 | 0.271 |
| Stomach discomfort | 4 | 25 | 0 | 0 | 0.142 |
*
Occurred in more than 5% of the subjects taking aripiprazole and was at least twice as common as in the placebo group.